On June 2, 2023, drug manufacturer Shire US Inc. and related entity Shire LLC (collectively, “Shire”) asked the Supreme Court to review an Eleventh Circuit ruling involving the interplay between state ...
On September 19, 2023, the U.S. Food and Drug Administration (“FDA” or “the Agency”) published a draft guidance, Regulatory Considerations for Prescription Drug Use-Related Software (the “Guidance”) ...
Hosted on MSN
Drug labelling norms under review: Expiry date readability flagged; govt panel to examine packaging reforms
India’s top drug regulator has set up a sub-committee to revamp labelling norms on medicinal products after receiving consumer complaints about illegible expiry dates and glossy packaging that hampers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback